136 related articles for article (PubMed ID: 36731110)
21. [Pars plana vitrectomy due to the intravitreal hemorrhage caused by persistent hyaloid artery in three children].
Stěpánková J; Dotřelová D
Cesk Slov Oftalmol; 2013 Dec; 69(6):243-7. PubMed ID: 24697536
[TBL] [Abstract][Full Text] [Related]
22. A pilot study of viscoelastic agent to prevent recurrent vitreous hemorrhage after vitrectomy for proliferative diabetic retinopathy.
Qiu CY; Shi YY; Zhao HW; Gong YB; Nie C; Wang MG; Jia R; Zhao J; Wang X; Luo L
BMC Ophthalmol; 2022 Dec; 22(1):509. PubMed ID: 36550421
[TBL] [Abstract][Full Text] [Related]
23. Gas Tamponade for the Prevention of Postoperative Vitreous Hemorrhaging After Diabetic Vitrectomy: A Randomized Clinical Trial.
Rush RB; Velazquez JC; Rosales CR; Rush SW
Am J Ophthalmol; 2022 Oct; 242():173-180. PubMed ID: 35764103
[TBL] [Abstract][Full Text] [Related]
24. SURGICAL OUTCOMES OF PARS PLANA VITRECTOMY FOR INTRAOCULAR COMPLICATIONS RELATED TO VASOPROLIFERATIVE TUMOR OF THE RETINA.
Jong JLZ; Jawaheer L; Spiteri-Cornish K; Chawla A
Retina; 2023 Nov; 43(11):1980-1987. PubMed ID: 37418640
[TBL] [Abstract][Full Text] [Related]
25. Predictors of visual outcome after pars plana vitrectomy secondary to proliferative diabetic retinopathy.
Nisic F; Gadzo AP; Fajkic A; Nisic A; Miokovic AP; Damjanovic G; Begic E; Beslic N; Lepara O
Rom J Ophthalmol; 2023; 67(3):283-288. PubMed ID: 37876512
[No Abstract] [Full Text] [Related]
26. Intravitreal Aflibercept injection with Panretinal photocoagulation versus early Vitrectomy for diabetic vitreous hemorrhage: randomized clinical trial.
Abd Elhamid AH; Mohamed AAEA; Khattab AM
BMC Ophthalmol; 2020 Apr; 20(1):130. PubMed ID: 32252674
[TBL] [Abstract][Full Text] [Related]
27. Outcomes of Pars Plana Vitrectomy with Panretinal Photocoagulation for Treatment of Proliferative Diabetic Retinopathy Without Retinal Detachment: A Seven-Year Retrospective Study.
Patel V; Rohowetz LJ; Pakravan P; Kalavar M; Yannuzzi NA; Sridhar J
Clin Ophthalmol; 2023; 17():471-478. PubMed ID: 36755887
[TBL] [Abstract][Full Text] [Related]
28. SILICONE OIL VERSUS PERFLUOROPROPANE GAS TAMPONADE DURING VITRECTOMY FOR TRACTIONAL RETINAL DETACHMENT OR FIBROUS PROLIFERATION: A Randomized Clinical Trial.
Rush RB; Del Valle Penella A; Reinauer RM; Rush SW; Bastar PG
Retina; 2021 Jul; 41(7):1407-1415. PubMed ID: 33252584
[TBL] [Abstract][Full Text] [Related]
29. Long-term outcomes of sutureless 25-G+ pars-plana vitrectomy for the management of diabetic tractional retinal detachment.
Mikhail M; Ali-Ridha A; Chorfi S; Kapusta MA
Graefes Arch Clin Exp Ophthalmol; 2017 Feb; 255(2):255-261. PubMed ID: 27480177
[TBL] [Abstract][Full Text] [Related]
30. 23-gauge vitrectomy in 100 eyes: short-term visual outcomes and complications.
Lott MN; Manning MH; Singh J; Zhang H; Singh H; Marcus DM
Retina; 2008 Oct; 28(9):1193-200. PubMed ID: 18626419
[TBL] [Abstract][Full Text] [Related]
31. [Minimally invasive vitrectomy for the treatment of severe proliferative diabetic retinopathy].
Zheng CZ; Ren XJ; Ke YF; Wen DJ; Li XR
Zhonghua Yan Ke Za Zhi; 2021 Jun; 57(6):440-446. PubMed ID: 34098693
[No Abstract] [Full Text] [Related]
32. Prophylactic intravitreal injection of aflibercept for preventing postvitrectomy hemorrhage in proliferative diabetic retinopathy: A randomized controlled trial.
Qu J; Chen X; Liu Q; Wang F; Li M; Zhou Q; Yao J; Li X
Front Public Health; 2022; 10():1067670. PubMed ID: 36711366
[TBL] [Abstract][Full Text] [Related]
33. Early postoperative retinal thickness changes and complications after vitrectomy for diabetic macular edema.
Yamamoto T; Hitani K; Tsukahara I; Yamamoto S; Kawasaki R; Yamashita H; Takeuchi S
Am J Ophthalmol; 2003 Jan; 135(1):14-9. PubMed ID: 12504691
[TBL] [Abstract][Full Text] [Related]
34. Anti-vascular endothelial growth factor for prevention of postoperative vitreous cavity haemorrhage after vitrectomy for proliferative diabetic retinopathy.
Smith JM; Steel DH
Cochrane Database Syst Rev; 2015 Aug; 2015(8):CD008214. PubMed ID: 26250103
[TBL] [Abstract][Full Text] [Related]
35. Vitrectomy for proliferative diabetic retinopathy with severe equatorial fibrovascular proliferation.
Han DP; Pulido JS; Mieler WF; Johnson MW
Am J Ophthalmol; 1995 May; 119(5):563-70. PubMed ID: 7733181
[TBL] [Abstract][Full Text] [Related]
36. Outpatient fluid-air exchange for severe postvitrectomy diabetic vitreous hemorrhage. Long-term results and complications.
Han DP; Murphy ML; Mieler WF; Abrams GW
Retina; 1991; 11(3):309-14. PubMed ID: 1961989
[TBL] [Abstract][Full Text] [Related]
37. Efficacy of Intravitreal Dexamethasone After Combined Phacoemulsification and Pars Plana Vitrectomy for Diabetic Tractional Retinal Detachments.
Limon U; Sezgin Akçay BI
J Ocul Pharmacol Ther; 2022 Mar; 38(2):176-182. PubMed ID: 34665023
[No Abstract] [Full Text] [Related]
38. The effect of adjunctive intravitreal bevacizumab for preventing postvitrectomy hemorrhage in proliferative diabetic retinopathy.
Ahn J; Woo SJ; Chung H; Park KH
Ophthalmology; 2011 Nov; 118(11):2218-26. PubMed ID: 21724263
[TBL] [Abstract][Full Text] [Related]
39. Can a preoperative bevacizumab injection prevent recurrent postvitrectomy diabetic vitreous haemorrhage?
Romano MR; Gibran SK; Marticorena J; Wong D; Heimann H
Eye (Lond); 2009 Aug; 23(8):1698-701. PubMed ID: 19039332
[TBL] [Abstract][Full Text] [Related]
40. Evaluation of vitrectomy combined preoperative intravitreal ranibizumab and postoperative intravitreal triamcinolone acetonide for proliferative diabetic retinopathy.
Hu L; Chen Q; Du Z; Wang W; Zhao G
Int Ophthalmol; 2021 May; 41(5):1635-1642. PubMed ID: 33538931
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]